Has William Gealy, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,449 in general payments to William Gealy, MD across 20 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean William Gealy, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about William Gealy, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

William Gealy, MD

Ophthalmology · Templeton, CANPI 1013922467

Payments from drug & device makers

$1,449in general payments, 2019–2025

Across 20 payments — averaging $72.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Glaukos Corporation$457
Genentech USA, Inc.$349
Regeneron Healthcare Solutions, Inc.$248
Alcon$233
Shire North American Group Inc$109
Bausch & Lomb Americas Inc.$35
plus $19 from 1 others

What the payments were for

Food & beverage$1,449100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Glaukos Corporation	3	$457
Genentech USA, Inc.	4	$349
Regeneron Healthcare Solutions, Inc.	2	$248
Alcon	7	$233
Shire North American Group Inc	1	$109
Bausch & Lomb Americas Inc.	2	$35
Iridex Corporation	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VABYSMO$257
EYLEA$248
iStent Inject Trabecular Micro-Bypass System$169
iS3-iStent infiniteTrabecular Micro-Bypass System Model iS3$169
KXL System$119
Photrexa$119
XIIDRA$109

How this compares

$1,449 in reported general payments places this provider in the 50th percentile of 2,513 ophthalmology providers in California.

See all ophthalmology providers in California →

Medicare billing

Part B allowed, 2024

$279,751

Medicare patients

570

Services billed

3,083

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
LumiganBimatoprost	26	$17,888
RocklatanNetarsudil Mesylat/Latanoprost	21	$15,719
RestasisCyclosporine	11	$12,535
Cyclosporine	16	$7,237
Fluorometholone	110	$6,104
Prednisolone Acetate	147	$5,743
CombiganBrimonidine Tartrate/Timolol	11	$3,474
Latanoprost	191	$2,741
Brimonidine Tartrate	49	$2,737
Ofloxacin	99	$1,020
Tobramycin-DexamethasoneTobramycin/Dexamethasone	20	$923
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol	11	$812
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	23	$489
Timolol Maleate	33	$371
Atropine Sulfate	11	$308

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Templeton

Nisha AcharyaSan Francisco$33M
David WirtaNewport Beach$18.4M
Michael IpPasadena$10.2M
Raymond DouglasBeverly Hills$9.7M
Sherif El HaraziGlendale$9.2M
Daniel SchwartzSan Francisco$8M
Nikolas Londonla Jolla$6.1M
Michael BerlinWest Hollywood$5.7M
Steven JacobsonLos Angeles$4.7M
Peter WinArcadia$4.2M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →